Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Intellia Therapeutics, Inc. - Common Stock (NQ:NTLA)

15.44 -1.40 (-8.31%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 9, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	7,379,558
Open	16.59
Bid (Size)	15.39 (100)
Ask (Size)	15.41 (100)
Prev. Close	16.84
Today's Range	15.14 - 17.16
52wk Range	7.950 - 28.25
Shares Outstanding	88,140,978
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

A New CRISPR "DNA Shredder" Could Change Gene-Editing -- What It Means for CRISPR Therapeutics ↗

July 08, 2026

This new technology could one day significantly expand the market for gene-editing biotechs.

Via The Motley Fool

Wall Street Thinks This High-Flying Biotech Stock Can Soar Another 57% ↗

July 01, 2026

It might pull it off, provided several things fall right in place.

Via The Motley Fool

Performance

YTD	+67.6%	+67.6%
1 Month	+14.5%	+14.5%
3 Month	+11.3%	+11.3%
6 Month	+52.4%	+52.4%
1 Year	+38.8%	+38.8%

More News

Wall Street Expects This Growth Stock That's Already Climbed 70% to Almost Double -- And Here's Why. ↗

June 24, 2026

Via The Motley Fool

Intellia Therapeutics Inc (NASDAQ:NTLA) Reports Strong Q4 2025 Revenue Beat and Confirms Key 2026 Pipeline Milestones ↗

February 26, 2026

Via Chartmill

Intellia Therapeutics vs. Omeros: Which Emerging Biotech Stock Is a Better Buy in 2026? ↗

June 20, 2026

Via The Motley Fool

This Stock Is Up 58% This Year. Is It too Late to Buy? ↗

June 17, 2026

Via The Motley Fool

1 Sector Warren Buffett and Greg Abel Are Largely Ignoring -- and Why Investors Shouldn't ↗

June 03, 2026

Via The Motley Fool

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

May 06, 2026

Via The Motley Fool

3 Biotech Stocks That Could Benefit from the Patent Cliff ↗

April 27, 2026

Via MarketBeat

Top movers in Friday's after hours session ↗

April 24, 2026

Via Chartmill

2 Healthcare Stocks to Buy and 1 to Approach With Caution ↗

April 15, 2026

Via The Motley Fool

This Cathie Wood Stock Is Up 47% This Year: Is It Too Late to Buy? ↗

March 08, 2026

Via The Motley Fool

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

March 03, 2026

Via The Motley Fool

Investors Eye Explosive Growth in Anti-Aging Therapies as Market Targets $420B Milestone

March 03, 2026

Via FinancialNewsMedia

Why Did NTLA Stock Jump 10% In Pre-Market Today? ↗

March 02, 2026

Via Stocktwits

Intellia (NTLA) Q4 2025 Earnings Call Transcript ↗

February 26, 2026

Via The Motley Fool

This Cathie Wood Stock Is Already Up 41% This Year, But Is It a Buy? ↗

February 07, 2026

Via The Motley Fool

NTLA Stock Jumped 13% Today – What Is The Latest FDA Action All About? ↗

January 27, 2026

Via Stocktwits

Nasdaq, S&P 500 Futures Edge Higher Ahead Of Long Weekend: Why NVDA, MU, NTLA, ASTS Are On Traders' Radar Today ↗

January 16, 2026

Via Stocktwits

Cathie Wood’s ARK Made Just One Buy Last Session — And It’s A Biotech Stock Up Nearly 30% YTD ↗

January 16, 2026

Via Stocktwits

Intellia CEO Sells $314K in Stock While Holding Over 1 Million Shares ↗

January 12, 2026

Via The Motley Fool

Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026

December 31, 2025

Via MarketMinute

2 Beaten-Down Stocks That Will Soar in 2026, According to Wall Street ↗

December 29, 2025

Via The Motley Fool

How BridgeBio, A Top 4% Stock, Is Lining Up Dominos On Its Triple-Digit Sprint ↗

December 02, 2025

Via Investor's Business Daily

Intellia (NTLA) Q3 2025 Earnings Call Transcript ↗

November 27, 2025

Via The Motley Fool

Frequently Asked Questions

Is Intellia Therapeutics, Inc. - Common Stock publicly traded?

Yes, Intellia Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Intellia Therapeutics, Inc. - Common Stock trade on?

Intellia Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Intellia Therapeutics, Inc. - Common Stock?

The ticker symbol for Intellia Therapeutics, Inc. - Common Stock is NTLA on the Nasdaq Stock Market

What is the current price of Intellia Therapeutics, Inc. - Common Stock?

The current price of Intellia Therapeutics, Inc. - Common Stock is 15.44

When was Intellia Therapeutics, Inc. - Common Stock last traded?

The last trade of Intellia Therapeutics, Inc. - Common Stock was at 07/09/26 04:00 PM ET

What is the market capitalization of Intellia Therapeutics, Inc. - Common Stock?

The market capitalization of Intellia Therapeutics, Inc. - Common Stock is 1.36B

How many shares of Intellia Therapeutics, Inc. - Common Stock are outstanding?

Intellia Therapeutics, Inc. - Common Stock has 1B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.